BlackRock’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$113M Buy
5,550,016
+25,884
+0.5% +$527K ﹤0.01% 1946
2025
Q1
$100M Buy
5,524,132
+43,462
+0.8% +$789K ﹤0.01% 1971
2024
Q4
$138M Buy
5,480,670
+600,650
+12% +$15.2M ﹤0.01% 1871
2024
Q3
$166M Buy
4,880,020
+189,259
+4% +$6.43M ﹤0.01% 1758
2024
Q2
$174M Buy
4,690,761
+178,837
+4% +$6.62M ﹤0.01% 1693
2024
Q1
$189M Buy
4,511,924
+836,232
+23% +$35.1M ﹤0.01% 1664
2023
Q4
$146M Buy
3,675,692
+423,738
+13% +$16.8M ﹤0.01% 1841
2023
Q3
$89.5M Buy
3,251,954
+29,967
+0.9% +$825K ﹤0.01% 2034
2023
Q2
$109M Sell
3,221,987
-28,651
-0.9% -$972K ﹤0.01% 1965
2023
Q1
$117M Buy
3,250,638
+25,922
+0.8% +$933K ﹤0.01% 1893
2022
Q4
$144M Buy
3,224,716
+94,303
+3% +$4.2M ﹤0.01% 1753
2022
Q3
$88M Sell
3,130,413
-21,056
-0.7% -$592K ﹤0.01% 2030
2022
Q2
$85M Buy
3,151,469
+104,647
+3% +$2.82M ﹤0.01% 2107
2022
Q1
$104M Sell
3,046,822
-54,208
-2% -$1.85M ﹤0.01% 2100
2021
Q4
$120M Sell
3,101,030
-32,740
-1% -$1.27M ﹤0.01% 2071
2021
Q3
$169M Buy
3,133,770
+433,120
+16% +$23.4M ﹤0.01% 1830
2021
Q2
$90.3M Buy
2,700,650
+1,732,777
+179% +$57.9M ﹤0.01% 2297
2021
Q1
$19.9M Buy
967,873
+106,492
+12% +$2.19M ﹤0.01% 3130
2020
Q4
$15.1M Buy
861,381
+69,785
+9% +$1.22M ﹤0.01% 3091
2020
Q3
$11.7M Buy
791,596
+379,144
+92% +$5.62M ﹤0.01% 3059
2020
Q2
$5.36M Buy
412,452
+67,969
+20% +$884K ﹤0.01% 3424
2020
Q1
$572K Buy
344,483
+2,264
+0.7% +$3.76K ﹤0.01% 3953
2019
Q4
$763K Sell
342,219
-273
-0.1% -$609 ﹤0.01% 4015
2019
Q3
$729K Buy
342,492
+1,554
+0.5% +$3.31K ﹤0.01% 4027
2019
Q2
$914K Buy
340,938
+37,820
+12% +$101K ﹤0.01% 3978
2019
Q1
$1.49M Buy
303,118
+178,593
+143% +$878K ﹤0.01% 3754
2018
Q4
$370K Sell
124,525
-128,919
-51% -$383K ﹤0.01% 4078
2018
Q3
$1.72M Buy
253,444
+14,882
+6% +$101K ﹤0.01% 3770
2018
Q2
$1.8M Sell
238,562
-434,603
-65% -$3.28M ﹤0.01% 3727
2018
Q1
$23.5M Buy
673,165
+11,118
+2% +$389K ﹤0.01% 2661
2017
Q4
$28.2M Buy
662,047
+18,619
+3% +$793K ﹤0.01% 2588
2017
Q3
$27.6M Buy
643,428
+19,590
+3% +$840K ﹤0.01% 2595
2017
Q2
$23.1M Buy
623,838
+82,484
+15% +$3.06M ﹤0.01% 2690
2017
Q1
$29.3M Buy
541,354
+539,778
+34,250% +$29.2M ﹤0.01% 2510
2016
Q4
$84K Buy
1,576
+64
+4% +$3.41K ﹤0.01% 2601
2016
Q3
$91K Buy
1,512
+31
+2% +$1.87K ﹤0.01% 2598
2016
Q2
$98K Buy
1,481
+1,045
+240% +$69.1K ﹤0.01% 2510
2016
Q1
$25K Buy
436
+245
+128% +$14K ﹤0.01% 2683
2015
Q4
$44K Buy
191
+31
+19% +$7.14K ﹤0.01% 2099
2015
Q3
$26K Hold
160
﹤0.01% 2198
2015
Q2
$61K Sell
160
-7
-4% -$2.67K ﹤0.01% 1870
2015
Q1
$70K Sell
167
-8
-5% -$3.35K ﹤0.01% 1811
2014
Q4
$48K Hold
175
﹤0.01% 1939
2014
Q3
$34K Hold
175
﹤0.01% 2049
2014
Q2
$43K Buy
175
+27
+18% +$6.63K ﹤0.01% 1957
2014
Q1
$39K Sell
148
-39
-21% -$10.3K ﹤0.01% 2002
2013
Q4
$68K Buy
187
+5
+3% +$1.82K ﹤0.01% 1799
2013
Q3
$97K Hold
182
﹤0.01% 1651
2013
Q2
$43K Buy
+182
New +$43K ﹤0.01% 1906